Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)

Vordermark, Dirk; Ruprecht, Klemens; Rieckmann, Peter; Roggendorf, Wolfgang; Vince, Giles H; Warmuth-Metz, Monika; Kölbl, Oliver; Flentje, Michael

doi:10.1186/1471-2407-6-247

BMC Cancer

Article metrics
Last updated: Wed, 24 Apr 2024 21:21:49 Z

Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)

Access & Citations

13k

Article Accesses
33

Web of Science
30

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com